Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125625561 | 12562556 | 1 | I | 20160411 | 20160715 | 20160715 | PER | US-NOVOPROD-488991 | NOVO NORDISK | 0.00 | A | M | Y | 0.00000 | 20160715 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125625561 | 12562556 | 1 | PS | Tresiba FlexTouch U200 | INSULIN DEGLUDEC | 1 | Subcutaneous | 70 U, QD | UNKNOWN | 203314 | 70 | DF | SOLUTION FOR INJECTION | QD | |||||
| 125625561 | 12562556 | 2 | SS | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | UNK | U | U | UNKNOWN | 0 | |||||||
| 125625561 | 12562556 | 3 | SS | INVOKANA | CANAGLIFLOZIN | 1 | Subcutaneous | UNK | U | U | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125625561 | 12562556 | 1 | Product used for unknown indication |
| 125625561 | 12562556 | 2 | Product used for unknown indication |
| 125625561 | 12562556 | 3 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125625561 | 12562556 | Blood glucose increased | |
| 125625561 | 12562556 | Hypoglycaemia | |
| 125625561 | 12562556 | Sleep disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |